Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

(2020) Manli Wang et al.   CELL RESEARCH

COVID-19 in Newborns and Infants—Low Risk of Severe Disease: Silver Lining or Dark Cloud?

(2020) Munmun Rawat et al.   AMERICAN JOURNAL OF PERINATOLOGY

Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?

(2020) Spinello Antinori et al.   AUTOIMMUNITY REVIEWS

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

(2020) Evangelos J. Giamarellos-Bourboulis et al.   Cell Host & Microbe

Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic

(2020) Zahra Belhadjer et al.   CIRCULATION

Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults

(2020) Supinda Bunyavanich et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Hyperinflammatory shock in children during COVID-19 pandemic

(2020) Shelley Riphagen et al.   LANCET

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

(2020) Yeming Wang et al.   LANCET

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

(2020) Lucio Verdoni et al.   LANCET

Children with Covid-19 in Pediatric Emergency Departments in Italy

(2020) Niccolò Parri et al.   NEW ENGLAND JOURNAL OF MEDICINE

On the Alert for Cytokine Storm: Immunopathology in COVID ‐19

(2020) Lauren A. Henderson et al.   Arthritis & Rheumatology

Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020

(2020) et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome

(2019) Olha Halyabar et al.   Pediatric Rheumatology

Dengue vaccine development: Global and Indian scenarios

(2019) Sathyamangalam Swaminathan et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

DNA Viremia Is Associated with Hyperferritinemia in Pediatric Sepsis

(2019) Dennis W. Simon et al.   JOURNAL OF PEDIATRICS

Usefulness and safety of anakinra in refractory Kawasaki disease complicated by coronary artery aneurysm

(2018) Marie-Paule Guillaume et al.   CARDIOLOGY IN THE YOUNG

Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis

(2018) Tom Parks et al.   CLINICAL INFECTIOUS DISEASES

Kawasaki Disease Shock Syndrome; A Unique and Severe Subtype of Kawasaki Disease

(2018) Luisa Berenise Gamez-Gonzalez et al.   PEDIATRICS INTERNATIONAL

Hemophagocytic Lymphohistiocytosis and Infections

(2018) Emily Chesshyre et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease – the SHARE initiative

(2018) Nienke de Graeff et al.   RHEUMATOLOGY

The Epidemiology and Pathogenesis of Kawasaki Disease

(2018) Anne H. Rowley et al.   Frontiers in Pediatrics

Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki’s Disease

(2017) Tomo Nozawa et al.   NEW ENGLAND JOURNAL OF MEDICINE

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

(2016) Angelo Ravelli et al.   ANNALS OF THE RHEUMATIC DISEASES

Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome

(2016) Bita Shakoory et al.   CRITICAL CARE MEDICINE

Clinical and Virologic Characteristics May Aid Distinction of Acute Adenovirus Disease from Kawasaki Disease with Incidental Adenovirus Detection

(2016) Eunkyung Song et al.   JOURNAL OF PEDIATRICS

Macrophage activation syndrome in the era of biologic therapy

(2016) Alexei A. Grom et al.   Nature Reviews Rheumatology

Marked hyperferritinemia does not predict for HLH in the adult population

(2015) A. M. Schram et al.   BLOOD

The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease

(2015) Jane C Burns et al.   Expert Review of Clinical Immunology

Early Differentiation of Kawasaki Disease Shock Syndrome and Toxic Shock Syndrome in a Pediatric Intensive Care Unit

(2015) Ying-Jui Lin et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange

(2014) Takuya Fujimaru et al.   CYTOKINE

Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

(2014) Sergio Davì et al.   Arthritis & Rheumatology

Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis

(2012) S. Chen et al.   HEART

Kawasaki disease: an unexpected etiology of shock and multiple organ dysfunction syndrome

(2012) Pauline Gatterre et al.   INTENSIVE CARE MEDICINE

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

(2012) Tohru Kobayashi et al.   LANCET

Vaccine Adjuvants: Putting Innate Immunity to Work

(2010) Robert L. Coffman et al.   IMMUNITY

Macrophage Activation Syndrome in the Acute Phase of Kawasaki Disease

(2010) Giuseppe A. Latino et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Recognition of a Kawasaki Disease Shock Syndrome

(2009) J. T. Kanegaye et al.   PEDIATRICS

Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis

(2009) Sebastiaan J. Vastert et al.   RHEUMATOLOGY